相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Treatment With Anti-CD20 and Oral Anti-CD3 Prevents and Reverses Autoimmune Diabetes
Changyun Hu et al.
DIABETES (2013)
Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
Ghanashyam Sarikonda et al.
PLOS ONE (2013)
Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures
Alberto M. Davalli et al.
ACTA DIABETOLOGICA (2012)
Effective treatment of rat adjuvant-induced arthritis by celastrol
R. Cascao et al.
AUTOIMMUNITY REVIEWS (2012)
Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro
I. Stojanovic et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleuldn-1 Blockade
Vitaly Ablamunits et al.
DIABETES (2012)
Long-Term Remission of Diabetes in NOD Mice Is Induced by Nondepleting Anti-CD4 and Anti-CD8 Antibodies
Zuoan Yi et al.
DIABETES (2012)
The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial-Type 1
Jay M. Sosenko et al.
DIABETES (2012)
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Tatiana Takiishi et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Expanding the Clinical Indications for α1-Antitrypsin Therapy
Eli C. Lewis
MOLECULAR MEDICINE (2012)
A call for transparent reporting to optimize the predictive value of preclinical research
Story C. Landis et al.
NATURE (2012)
Development of B Cells and Erythrocytes Is Specifically Impaired by the Drug Celastrol in Mice
Sophie Kusy et al.
PLOS ONE (2012)
The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
Abdoreza Davoodi-Semiromi et al.
PLOS ONE (2012)
NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice
Lakshmimathy Subramanian et al.
PLOS ONE (2012)
Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example
Gerardo M. Castillo et al.
PHARMACEUTICAL RESEARCH (2012)
Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function
Li-Fen Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mixed Chimerism and Growth Factors Augment β Cell Regeneration and Reverse Late-Stage Type 1 Diabetes
Miao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis
Sander van der Marel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Interleukin-21 Is Critically Required in Autoimmune and Allogeneic Responses to Islet Tissue in Murine Models
Helen M. McGuire et al.
DIABETES (2011)
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse
Michele M. Kosiewicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Evaluating Preclinical Efficacy
Mark A. Atkinson
SCIENCE TRANSLATIONAL MEDICINE (2011)
Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus
Douglas O. Sobel et al.
ACTA DIABETOLOGICA (2010)
Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes
Pilar Londono et al.
CLINICAL IMMUNOLOGY (2010)
Infection With Viruses From Several Families Triggers Autoimmune Diabetes in LEW.1WR1 Rats Prevention of Diabetes by Maternal Immunization
Rebecca S. Tirabassi et al.
DIABETES (2010)
A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice
Andrea Vergani et al.
DIABETES (2010)
Intradermal α1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease
H. Ma et al.
DIABETOLOGIA (2010)
Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice
Devangi S. Mehta et al.
IMMUNOLOGY (2010)
Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
Song Xue et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8+ T Cell Activity
Akiko Yamada et al.
PLOS ONE (2010)
In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes
Daniel J. Moore et al.
PLOS ONE (2010)
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
Juliet A. Emamaullee et al.
DIABETES (2009)
A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis
Nilesh M. Dagia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Suppression of Autoimmune Diabetes by Soluble Galectin-1
Marcelo J. Perone et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Cord Blood Stem Cell-Modulated Regulatory T Lymphocytes Reverse the Autoimmune-Caused Type 1 Diabetes in Nonobese Diabetic (NOD) Mice
Yong Zhao et al.
PLOS ONE (2009)
Upregulating CD4+CD25+FOXP3+ Regulatory T Cells in Pancreatic Lymph Nodes in Diabetic NOD Mice by Adjuvant Immunotherapy
Bole Tian et al.
TRANSPLANTATION (2009)
Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network
Jay S. Skyler et al.
Immunology of Diabetes V: From Bench to Bedside (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Glucagon Like Peptides-1 Modulators as Newer Target for Diabetes
H. B. Vaidya et al.
CURRENT DRUG TARGETS (2008)
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
Paolo Fiorina et al.
DIABETES (2008)
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice
Maria Koulmanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Essential roles of TGF-β in anti-CD3 antibody therapy:: reversal of diabetes in nonobese diabetic mice independent of Foxp3+ CD4+ regulatory T cells
Guojiang Chen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat-fed mice
Benjamin J. Lamont et al.
DIABETES (2008)
Exendin-4 improves reversal of diabetes in NOD mice treated with Anti-CD3 monoclonal antibody by enhancing recovery of β-cells
Nicole A. Sherry et al.
ENDOCRINOLOGY (2007)
Type IINKT cell-mediated anergy induction in type INKT cells prevents inflammatory liver disease
Ramesh C. Halder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration
Jenny M. Phillips et al.
DIABETES (2007)
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes
Zandong Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
α1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice
Yuanqing Lu et al.
HUMAN GENE THERAPY (2006)
LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation
JP Mordes et al.
DIABETES (2005)
The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation
ZD Yang et al.
TRANSPLANTATION (2004)
Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice
J Bojunga et al.
CYTOKINE (2003)
The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice
ZD Yang et al.
DIABETOLOGIA (2002)
分享论文
